These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1638552)

  • 1. Comparative biological properties of a recombinant chimeric anti-carcinoma mAb and a recombinant aglycosylated variant.
    Hand PH; Calvo B; Milenic D; Yokota T; Finch M; Snoy P; Garmestani K; Gansow O; Schlom J; Kashmiri SV
    Cancer Immunol Immunother; 1992; 35(3):165-74. PubMed ID: 1638552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation and characterization of a recombinant/chimeric B72.3 (human gamma 1).
    Hutzell P; Kashmiri S; Colcher D; Primus FJ; Hand PH; Roselli M; Finch M; Yarranton G; Bodmer M; Whittle N
    Cancer Res; 1991 Jan; 51(1):181-9. PubMed ID: 1988082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic properties of a CH2 domain-deleted recombinant immunoglobulin.
    Slavin-Chiorini DC; Horan Hand PH; Kashmiri SV; Calvo B; Zaremba S; Schlom J
    Int J Cancer; 1993 Jan; 53(1):97-103. PubMed ID: 8416208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and biodistribution of recombinant and recombinant/chimeric constructs of monoclonal antibody B72.3.
    Colcher D; Milenic D; Roselli M; Raubitschek A; Yarranton G; King D; Adair J; Whittle N; Bodmer M; Schlom J
    Cancer Res; 1989 Apr; 49(7):1738-45. PubMed ID: 2924317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimeric B72.3 mouse/human (IgG1) antibody directs the lysis of tumor cells by lymphokine-activated killer cells.
    Primus FJ; Pendurthi TK; Hutzell P; Kashmiri S; Slavin DC; Callahan R; Schlom J
    Cancer Immunol Immunother; 1990; 31(6):349-57. PubMed ID: 2386980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological properties of chimeric domain-deleted anticarcinoma immunoglobulins.
    Slavin-Chiorini DC; Kashmiri SV; Schlom J; Calvo B; Shu LM; Schott ME; Milenic DE; Snoy P; Carrasquillo J; Anderson K
    Cancer Res; 1995 Dec; 55(23 Suppl):5957s-5967s. PubMed ID: 7493377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A CDR-grafted (humanized) domain-deleted antitumor antibody.
    Slavin-Chiorini DC; Kashmiri SV; Lee HS; Milenic DE; Poole DJ; Bernon E; Schlom J; Hand PH
    Cancer Biother Radiopharm; 1997 Oct; 12(5):305-16. PubMed ID: 10851481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New chimeric anti-pancarcinoma monoclonal antibody with superior cytotoxicity-mediating potency.
    Velders MP; Litvinov SV; Warnaar SO; Gorter A; Fleuren GJ; Zurawski VR; Coney LR
    Cancer Res; 1994 Apr; 54(7):1753-9. PubMed ID: 8137290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49.
    Milenic DE; Yokota T; Filpula DR; Finkelman MA; Dodd SW; Wood JF; Whitlow M; Snoy P; Schlom J
    Cancer Res; 1991 Dec; 51(23 Pt 1):6363-71. PubMed ID: 1933899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and expression of two mouse-human chimeric antibodies with high specificity and affinity for carcinoembryonic antigen.
    Arakawa F; Haruno M; Kuroki M; Kanda H; Watanabe T; Misumi Y; Matsuoka Y
    Hybridoma; 1993 Aug; 12(4):365-79. PubMed ID: 8244416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing.
    Coney LR; Mezzanzanica D; Sanborn D; Casalini P; Colnaghi MI; Zurawski VR
    Cancer Res; 1994 May; 54(9):2448-55. PubMed ID: 7512887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Full-length recombinant antibodies from
    Rashid MH
    MAbs; 2022; 14(1):2111748. PubMed ID: 36018829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigen.
    Muraro R; Kuroki M; Wunderlich D; Poole DJ; Colcher D; Thor A; Greiner JW; Simpson JF; Molinolo A; Noguchi P
    Cancer Res; 1988 Aug; 48(16):4588-96. PubMed ID: 3396010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementation of intracavitary and intravenous administration of a monoclonal antibody (B72.3) in patients with carcinoma.
    Colcher D; Esteban J; Carrasquillo JA; Sugarbaker P; Reynolds JC; Bryant G; Larson SM; Schlom J
    Cancer Res; 1987 Aug; 47(15):4218-24. PubMed ID: 3607761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and biodistribution of a light-chain-shuffled CC49 single-chain Fv antibody construct.
    Pavlinkova G; Colcher D; Booth BJ; Goel A; Batra SK
    Cancer Immunol Immunother; 2000 Jul; 49(4-5):267-75. PubMed ID: 10941910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aglycosylated chimeric mouse/human IgG1 antibody retains some effector function.
    Dorai H; Mueller BM; Reisfeld RA; Gillies SD
    Hybridoma; 1991 Apr; 10(2):211-7. PubMed ID: 1874515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and characterization of a high-affinity chimeric anti-colorectal carcinoma antibody ccM4.
    Xiang J; Moyana T; Kalra J; Hamilton T; Qi Y
    Mol Biother; 1992 Dec; 4(4):174-83. PubMed ID: 1476671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation, characterization, and in vivo studies of humanized anticarcinoma antibody CC49.
    Kashmiri SV; Shu L; Padlan EA; Milenic DE; Schlom J; Hand PH
    Hybridoma; 1995 Oct; 14(5):461-73. PubMed ID: 8575795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and purification of domain-deleted immunoglobulin variants of the recombinant/chimeric B72.3 (y1) monoclonal antibody.
    Calvo B; Kashmiri SV; Hutzell P; Hand PH; Slavin-Chiorini DC; Schlom J; Zaremba S
    Cancer Biother; 1993; 8(1):95-109. PubMed ID: 7529083
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.